bearish•PureTech Health•10 Oct 2022 18:28
PureTech Health (PRTC LN): Possible Combination with Nektar Is Just a Defensive Move
Puretech shares gained ~20% since my bullish insight on the company on May 31. Investors should book profit amid uncertainty regarding possibility...
bullish•Nektar Therapeutics•13 Dec 2021 00:57
Nektar Therapeutics (NKTR US): A Good Buying Option in Immuno-Oncology Therapeutic Area
Nektar presented favorable clinical data for its lead candidate, bempeg at a global healthcare conference recently. Bempeg, a potential blockbuster...
bullish•Factset Research Systems Inc•05 Dec 2021 12:13
S&P500 Index Rebalance: Migrations Across the Indices
There are 3 migrations from the S&P400 to the S&P500 and vice versa and another 3 migrations from the S&P600 to the S&400 and vice versa. The one...
bearish•S&P 500 INDEX•20 May 2020 07:34
U.S. Equity Strategy: Round Trip Back To Resistance
Our base case continues to be for near-term consolidation while the market determines the implications of states’ reopening (i.e., the...
bullish•Nektar Therapeutics•15 Feb 2018 23:40